Top

Published in:

01-04-2012 | Original Article

α-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections

Authors: Isabel Ubeda-Bañon, Daniel Saiz-Sanchez, Carlos de la Rosa-Prieto, Alino Martinez-Marcos

Published in: Brain Structure and Function | Issue 2/2012

Abstract

Olfactory deficits are an early feature of Parkinson’s disease (PD). Neuropathologically, α-synucleinopathy (Lewy bodies and neurites) is observed earlier (stage 1) in the olfactory system than in the substantia nigra (stage 3), and this could underlies the early olfactory symptoms. In the present report, we analyzed the distribution of α-synuclein deposits in tertiary olfactory structures (anterior olfactory nucleus, olfactory tubercle, piriform cortex, posterolateral cortical amygdala and lateral entorhinal cortex) of homozygous transgenic mice (aged 2–8 months) overexpressing the human A53T variant of α-synuclein. To address the hypothesis of progressive α-synucleinopathy within the olfactory system, the distribution of α-synuclein was analyzed in conjunction with tracer injections into the main olfactory bulb. The time-course of α-synuclein expression revealed a significant increase in the piriform cortex at the age of 8 months compared to other brain structures. Tracing experiments revealed that olfactory projections are reduced in homozygous as compared to wild type animals. Double-labeling experiments show labeled axonal collaterals of mitral cells entering layer II of the piriform cortex in close proximity to α-synuclein-positive cells. To our knowledge, this is the first study addressing the progression of α-synuclein expression in a vulnerable neuronal pathway in PD.

Angot E et al (2010) Are synucleinopathies prion-like disorders? Lancet Neurol 9:1128–1138PubMedCrossRef

Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson’s disease. J Chronic Dis 28:493–497PubMedCrossRef

Beach TG et al (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174PubMedCrossRef

Benarroch EE (2010) Olfactory system: functional organization and involvement in neurodegenerative disease. Neurology 75:1104–1109PubMedCrossRef

Braak H et al (2003a) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef

Braak H et al (2003b) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517–536PubMedCrossRef

Braak H et al (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72PubMedCrossRef

Brundin P et al (2008) Research in motion: the enigma of Parkinson’s disease pathology spread. Nat Rev Neurosci 9:741–745PubMedCrossRef

Brunjes PC et al (2005) A field guide to the anterior olfactory nucleus (cortex). Brain Res Brain Res Rev 50:305–335PubMedCrossRef

Constantinidis J, de Ajuriaguerra J (1970) Familial syndrome with parkinsonian tremor and anosmia and its therapy with l-dopa associated with a decarboxylase inhibitor. Therapeutique 46:263–269PubMed

Daniel SE, Hawkes CH (1992) Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology. Lancet 340:186PubMedCrossRef

Davis BJ et al (1978) Efferents and centrifugal afferents of the main and accessory olfactory bulbs in the hamster. Brain Res Bull 3:59–72PubMedCrossRef

Dawson T et al (2002) Animal models of PD: pieces of the same puzzle? Neuron 35:219–222PubMedCrossRef

Deierborg T et al (2008) Emerging restorative treatments for Parkinson’s disease. Prog Neurobiol 85:407–432PubMedCrossRef

Del Tredici K et al (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426PubMed

Devor M (1976) Fiber trajectories of olfactory bulb efferents in the hamster. J Comp Neurol 166:31–47PubMedCrossRef

Duda JE (2010) Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289:49–54PubMedCrossRef

Fahn S (2008) The history of dopamine and levodopa in the treatment of Parkinson’s disease. Mov Disord 23(Suppl 3):S497–S508PubMedCrossRef

Fleming SM et al (2005) Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2:495–503PubMedCrossRef

Fleming SM et al (2008) Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 28:247–256PubMedCrossRef

Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates. Elsevier, San Diego

Giasson BI et al (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521–533PubMedCrossRef

Gutierrez-Castellanos N et al (2010) Chemosensory function of the amygdala. Vitam Horm 83:165–196PubMedCrossRef

Haehner A et al (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22:839–842PubMedCrossRef

Hawkes CH (2008) The prodromal phase of sporadic Parkinson’s disease: does it exist and if so how long is it? Mov Disord 23:1799–1807PubMedCrossRef

Hawkes CH, Shephard BC (1993) Selective anosmia in Parkinson’s disease? Lancet 341:435–436PubMedCrossRef

Hubbard PS et al (2007) Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat 211:117–124PubMedCrossRef

Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17:417–423PubMedCrossRef

Kim YH et al (2011) Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 172:379–386PubMedCrossRef

Kordower JH et al (2008) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303–2306PubMedCrossRef

Kranick SM, Duda JE (2008) Olfactory dysfunction in Parkinson’s disease. Neurosignals 16:35–40PubMedCrossRef

Lee MK et al (2002) Human alpha-synuclein-harboring familial Parkinson’s disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A. 99:8968–8973PubMedCrossRef

Lees AJ et al (2009) Parkinson’s disease. Lancet 373:2055–2066PubMedCrossRef

Lerner A, Bagic A (2008) Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 23:1076–1084PubMedCrossRef

Li JY et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med 14:501–503PubMedCrossRef

Marek K, Jennings D (2009) Can we image premotor Parkinson disease? Neurology 72:S21–S26PubMedCrossRef

Martinez-Marcos A (2009) On the organization of olfactory and vomeronasal cortices. Prog Neurobiol 87:21–30PubMedCrossRef

Martinez-Marcos A, Halpern M (2006) Efferent connections of the main olfactory bulb in the opossum (Monodelphis domestica): a characterization of the olfactory entorhinal cortex in a marsupial. Neurosci Lett 395:51–56PubMedCrossRef

Morley JF, Duda JE (2010) Olfaction as a biomarker in Parkinson’s disease. Biomark Med 4:661–670PubMedCrossRef

Morley JF, Hurtig HI (2010) Current understanding and management of Parkinson disease: five new things. Neurology 75:S9–S15PubMedCrossRef

Müller A et al (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9:521–524PubMedCrossRef

Pearce RK et al (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10:283–287PubMedCrossRef

Ponsen MM et al (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181PubMedCrossRef

Richfield EK et al (2002) Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol 175:35–48PubMedCrossRef

Ross GW et al (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173PubMedCrossRef

Saiz-Sanchez D et al (2010) Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease. Exp Neurol 223:347–350PubMedCrossRef

Saiz-Sanchez D et al (2010a) The human olfactory system: an anatomical and cytoarchitectonic study of the anterior olfactory nucleus. In: Flynn CE, Callaghan BR (eds) Neuroanatomy Research Advances, New York, p 171–182

Savica R et al (2010) When does Parkinson disease start? Arch Neurol 67:798–801PubMedCrossRef

Sengoku R et al (2008) Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072–1083PubMedCrossRef

Shipley MT, Adamek GD (1984) The connections of the mouse olfactory bulb: a study using orthograde and retrograde transport of wheat germ agglutinin conjugated to horseradish peroxidase. Brain Res Bull 12:669–688PubMedCrossRef

Siderowf A, Stern MB (2008) Premotor Parkinson’s disease: clinical features, detection, and prospects for treatment. Ann Neurol 64(Suppl 2):S139–S147PubMed

Silveira-Moriyama L et al (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453:77–80PubMedCrossRef

Skeen LC, Hall WC (1977) Efferent projections of the main and the accessory olfactory bulb in the tree shrew (Tupaia glis). J Comp Neurol 172:1–35PubMedCrossRef

Sommer B et al (2000) Mouse models of alpha-synucleinopathy and Lewy pathology. Exp Gerontol 35:1389–1403PubMedCrossRef

Spillantini MG et al (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840PubMedCrossRef

Tolosa E et al (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72:S12–S20PubMedCrossRef

Toulouse A, Sullivan AM (2008) Progress in Parkinson’s disease-where do we stand? Prog Neurobiol 85:376–392PubMedCrossRef

Ubeda-Banon I et al (2010a) Alpha-synucleinopathy in the human olfactory system in Parkinson’s disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol 119:723–735PubMedCrossRef

Ubeda-Banon I et al (2010b) Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson’s disease: cell types involved. Mov Disord 25:1701–1707PubMedCrossRef

Ubeda-Banon I et al (2011) Cladistic analysis of olfactory and vomeronasal systems. Front Neuroanat 5:3PubMedCrossRef

van der Putten H et al (2000) Neuropathology in mice expressing human alpha-synuclein. J Neurosci 20:6021–6029PubMed

Vidailhet M (2011) Movement disorders in 2010: Parkinson disease-symptoms and treatments. Nat Rev Neurol 7:70–72PubMedCrossRef

Title: α-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections
Authors: Isabel Ubeda-Bañon
Daniel Saiz-Sanchez
Carlos de la Rosa-Prieto
Alino Martinez-Marcos
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Brain Structure and Function / Issue 2/2012
Print ISSN: 1863-2653
Electronic ISSN: 1863-2661
DOI: https://doi.org/10.1007/s00429-011-0347-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

α-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia

Evaluation of methods for detecting perfusion abnormalities after stroke in dysfunctional brain regions

The red nucleus and the rubrospinal projection in the mouse

Reduction of cerebellar grey matter in Crus I and II in schizophrenia

Differential neuronal changes in medial prefrontal cortex, basolateral amygdala and nucleus accumbens after postweaning social isolation

Parasagittal compartmentation of cerebellar mossy fibers as revealed by the patterned expression of vesicular glutamate transporters VGLUT1 and VGLUT2